Review
Open access
Jul 2026
Targeting Residual Inflammation in Cardiovascular Disease: Beyond LDL Cholesterol Toward Precision Cardiometabolic Prevention
Current evidence supports a transition toward comprehensive cardiometabolic prevention integrating lipid management, lifestyle modification, metabolic optimization, and targeted anti-inflammatory therapy and future precision medicine strategies incorporating inflammatory biomarkers and individualized risk assessment may further improve cardiovascular outcomes and reduce the global burden of atherosclerotic disease.
Santiago Alberto Avila Ak, Ana Clemente, Rafaela Denisse Zambrano Mendieta et al.
· IECCMEXICO · 0 citations